| |
 |
Design of New Anti-Cancer Agents Based on Topoisomerase Poisons Targeted to Specific DNA Sequences
|
| |
|
pp.219-235 (17) Authors: P. B. Arimondo, C. Helene |
| |
|
|
| |
|
Naphthalimides as Anticancer Agents: Synthesis and Biological Activity
|
| |
|
pp.237-255 (19) Authors: M. F. Brana, A. Ramos |
| |
|
|
| |
|
Advances in the Chemistry and Pharmacology of Ecteinascidins, A Promising New Class of Anticancer Agents
|
| |
|
pp.257-276 (20) Authors: I. Manzanares, C. Cuevas, R. Garcia-Nieto, E. Marco, F. Gago |
| |
|
|
| |
|
Biospecific Interaction Analysis (BIA) as a Tool for the Design and Development of Gene Transcription Modifiers
|
| |
|
pp.277-291 (15) Author: Roberto Gambari |
| |
|
|
| |
|
Cytotoxic Activity of Styryl Lactones and their Derivatives
|
| |
|
pp.293-300 (8) Authors: Hari Babu Mereyala, Maju Joe |
| |
|
|
| |
|
Aminophosphonic Acids of Potential Medical Importance
|
| |
|
pp.301-312 (12) Authors: Pawel Kafarski, Barbara Lejczak |
| |
|
|
| |
|
Tumor Bone Diseases: Molecular Mechanisms and Opportunities for Novel Treatments
|
| |
|
pp.313-329 (17) Authors: Mira Susa, Markus Glatt, Anna Teti |
| |
|
|
